C vs LAB
Citigroup Inc. (C) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
C currently screens at market cap $214.73B and trailing P/E 15.5. LAB currently screens at market cap $317.1M.
Not investment advice. Open the C and LAB stock pages for the full models.
Not investment advice.